Diagnostic manufacturers are under pressure to deliver faster, more sensitive, and more stable assays. Traditional antibody generation is slow, costly, and inconsistent.
Aptamers offer a scalable, reproducible, and highly specific alternative — and AI makes them even better.
Neoncorte Bio provides AI/ML-driven aptamer design and affinity maturation tailored for diagnostic kit developers working on:
Our platform accelerates ligand discovery from months → weeks, while achieving therapeutic-grade affinity and selectivity.